62
36
Growth Score 62 in past quarter
-23 pts
Heat Score 36 in past quarter
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
703426
Kenox Pharmaceuticals provides aerosol-based technologies for generic molecules or new chemical entities.
- Julianne Berry: Vice President of R&D and ManufacturingPast Role: Odin Pharmaceuticals, Vice President of Respiratory Product Development
- Sitaram Velaga: Founder, President, and Chief Executive Officer
About the Company
Kenox Pharmaceuticals is an emerging specialty pharmaceutical company that provides aerosol-based technologies for generic molecules or new chemical entities. They provide research, development, and commercialization enterprise specializing in aerosol-based drug-delivery products for eye, nasal, oral, and inhalation applications.